drugset / Trial / NCT01546922

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)

NCT01546922

Phase 4 Completed 63 enrolled University Medical Center Groningen
RandomizedCrossoverDouble-blindTreatment

Summary

The aim of this study is to investigate whether a physiologically low hydrocortisone (HC) dose is better for cognition as compared to a physiologically high HC dose. In addition, quality of life, metabolic profile and somatosensation will be described in relation to HC dose.

Timeline

Start
2012-02
Primary completion
2013-06
Completion
2013-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 0.2 mg/kg Oral
Comparator Hydrocortisone Other / unclassified 0.3 mg/kg Oral
Comparator Hydrocortisone Other / unclassified 0.4 mg/kg Oral
Comparator Hydrocortisone Other / unclassified 0.6 mg/kg Oral